The Evotec stock is currently showing a very positive development, which should certainly be interesting for private investors and small investors. In recent days, the share price of the biotechnology company has significantly increased. On June 12, 2025, the stock price rose by +4.02% to 7.6080 euros, which means an increase of about 0.29 euros compared to the previous trading day. Already on June 9, the stock recorded a strong increase of +4.36%, indicating a consistently strong demand.
Positive Trend and Market Strength
This recent upward movement continues a positive trend reversal: Over the last three months, investors holding Evotec stocks have achieved a profit of around +16.63%. Compared to the previous week, the stock has become +3.38% more expensive. However, there have also been phases with price declines on a monthly comparison (about -4.99%), and since the beginning of the year, the price is still about -10.19% below the starting value of the year.
Strong Market Position of Evotec
Evotec is known as a leading biopharmaceutical company for its comprehensive services in drug research and development – from screening to clinical development – and has strong market positions in Europe and the USA. The company stands out due to its platform technology and strategic partnerships.
For investors, the current chart pattern represents a promising starting position with a clearly recognizable recovery trend after a difficult start to the year. The recent price gains could be a signal for further positive developments.
In summary:
- Current price increase on 12.06.: +4.02% to about 7.61 euros
- Three-month gain: about +16.63%
- Positive trend reversal after weak start to the year (-10% YTD)
- Strong market position and innovative technology at Evotec
- For private investors, this could be a good time to enter or expand their position
These factors make the current chart pattern “remarkably good” from the perspective of many investors.